InvivoCure — Van Nuys, California

InvivoCure is a clinical research site located in Van Nuys, California, United States 91405.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

InvivoCure has participated in 7 clinical trials with 7 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Peripheral Arterial Disease.

Sponsors: Eli Lilly and Company, Novo Nordisk A/S, Viatris Innovation GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Van Nuys

Browse all research sites in California · View every site in Van Nuys

• Valley Presbyterian Hospital
• GSK Investigational Site
• Medvin Clinical Research
• Research Site
• San Fernando Valley Health Institute
• Novo Nordisk Investigational Site
• Velocity Clinical Research, Panorama City
• Novartis Investigative Site
• Cardiovascular Consultants Medical Group
• Velocity Clin Res - Panorama
• Southern California Orthopedic Institute

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for InvivoCure?

InvivoCure has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has InvivoCure conducted?

InvivoCure has 7 clinical trials on record, with 7 currently active. Their work covers Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Peripheral Arterial Disease.

Is InvivoCure accredited by Crixeo Clinical Trials?

InvivoCure has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about InvivoCure?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.